drugset / Trial / NCT00198562

Hypertension Control Based on Home Blood Pressure

NCT00198562

RandomizedFactorialOpen-labelTreatment

Summary

The aim of this trial is to study the effects of antihypertensive therapy based on home systolic blood pressure (BP) with different target levels using two classes of drugs. The HOSP study is a multicenter, prospective, randomized, open, blinded endpoint study. The study subjects are 40-79 years old hypertensive patients. After a 4 weeks of baseline period, subjects are randomly assigned to (1) modest control group (morning home BP \<140 mmHg) or (2) strict control group (morning home BP \<130 mmHg), and to (a) amlodipine group or (b) losartan group. Additional antihypertensive drugs can be used if home BP is not controlled. Home BP is measured in the early morning and late evening. The participants will be followed up for 5 years.

Timeline

Start
2000-04
Primary completion
2012-03
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amlodipine Other / unclassified 2.5 mg
Comparator Amlodipine Other / unclassified 10 mg
Comparator Losartan Other / unclassified 25 mg
Comparator Losartan Other / unclassified 100 mg

Indications